FDA 483 - Wendy C. Daly, M.D. - July 01, 2019

An FDA inspection of Wendy C. Daly, M.D. in Louisville, KY, a clinical investigator, revealed significant issues in clinical trial conduct. Observations included the failure to report adverse events to the sponsor and the lack of accurate and complete case histories, with discrepancies between source documents and electronic case report forms.